Tracy Frech

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. ncbi Vascular leak is a central feature in the pathogenesis of systemic sclerosis
    Tracy M Frech
    Division of Rheumatology, Department of Internal Medicine, University of Utah, 4B200 SOM, 30 N 1900 E, Salt Lake City, Utah 84132, USA
    J Rheumatol 39:1385-91. 2012
  2. ncbi Heritability of vasculopathy, autoimmune disease, and fibrosis in systemic sclerosis: a population-based study
    Tracy Frech
    University of Utah, Division of Rheumatology, Department of Medicine, Salt Lake City, UT 84132, USA
    Arthritis Rheum 62:2109-16. 2010
  3. ncbi Probiotics for the treatment of systemic sclerosis-associated gastrointestinal bloating/ distention
    Tracy M Frech
    Division of Rheumatology, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA
    Clin Exp Rheumatol 29:S22-5. 2011
  4. ncbi Prevalence and correlates of sleep disturbance in systemic sclerosis--results from the UCLA scleroderma quality of life study
    Tracy Frech
    Department of Internal Medicine, Division of Rheumatology, University of Utah, Salt Lake City, UT, USA
    Rheumatology (Oxford) 50:1280-7. 2011
  5. ncbi Low-dose naltrexone for pruritus in systemic sclerosis
    Tracy Frech
    Division of Rheumatology, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA
    Int J Rheumatol 2011:804296. 2011
  6. ncbi Valuation of scleroderma and psoriatic arthritis health states by the general public
    Dinesh Khanna
    Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA
    Health Qual Life Outcomes 8:112. 2010

Detail Information

Publications6

  1. ncbi Vascular leak is a central feature in the pathogenesis of systemic sclerosis
    Tracy M Frech
    Division of Rheumatology, Department of Internal Medicine, University of Utah, 4B200 SOM, 30 N 1900 E, Salt Lake City, Utah 84132, USA
    J Rheumatol 39:1385-91. 2012
    ..We investigated the microvasculature alterations in the skin of patients with SSc at various stages of disease duration with whole-field digital microscopy...
  2. ncbi Heritability of vasculopathy, autoimmune disease, and fibrosis in systemic sclerosis: a population-based study
    Tracy Frech
    University of Utah, Division of Rheumatology, Department of Medicine, Salt Lake City, UT 84132, USA
    Arthritis Rheum 62:2109-16. 2010
    ..To investigate the familiality of systemic sclerosis (SSc) in relation to Raynaud's phenomenon (RP) (a marker of vasculopathy), other autoimmune inflammatory disease, and fibrotic interstitial lung disease (ILD)...
  3. ncbi Probiotics for the treatment of systemic sclerosis-associated gastrointestinal bloating/ distention
    Tracy M Frech
    Division of Rheumatology, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA
    Clin Exp Rheumatol 29:S22-5. 2011
    ..Our hypothesis is that GIT symptoms in SSc patients with moderate bloating would improve with probiotic implementation...
  4. ncbi Prevalence and correlates of sleep disturbance in systemic sclerosis--results from the UCLA scleroderma quality of life study
    Tracy Frech
    Department of Internal Medicine, Division of Rheumatology, University of Utah, Salt Lake City, UT, USA
    Rheumatology (Oxford) 50:1280-7. 2011
    ..Rheumatologic disorders are associated with sleep disturbances. This study examines sleep disturbance correlates in patients with SSc...
  5. ncbi Low-dose naltrexone for pruritus in systemic sclerosis
    Tracy Frech
    Division of Rheumatology, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA
    Int J Rheumatol 2011:804296. 2011
    ..0 (UCLA SCTC GIT 2.0) questionnaire. This small case series suggests LDN may be an effective, highly tolerable, and inexpensive treatment for pruritus and GIT symptoms in SSc...
  6. ncbi Valuation of scleroderma and psoriatic arthritis health states by the general public
    Dinesh Khanna
    Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, USA
    Health Qual Life Outcomes 8:112. 2010
    ..Our objective was to assess health values (utilities) from the general public for health states common to people with PsA and SSc for economic evaluations...